Correlation Between BGNE Old and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both BGNE Old and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BGNE Old and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BGNE Old and Blueprint Medicines Corp, you can compare the effects of market volatilities on BGNE Old and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BGNE Old with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of BGNE Old and Blueprint Medicines.
Diversification Opportunities for BGNE Old and Blueprint Medicines
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between BGNE and Blueprint is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding BGNE Old and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and BGNE Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BGNE Old are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of BGNE Old i.e., BGNE Old and Blueprint Medicines go up and down completely randomly.
Pair Corralation between BGNE Old and Blueprint Medicines
Given the investment horizon of 90 days BGNE Old is expected to generate 1.54 times less return on investment than Blueprint Medicines. But when comparing it to its historical volatility, BGNE Old is 1.06 times less risky than Blueprint Medicines. It trades about 0.05 of its potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 7,420 in Blueprint Medicines Corp on November 3, 2024 and sell it today you would earn a total of 3,833 from holding Blueprint Medicines Corp or generate 51.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 91.94% |
| Values | Daily Returns |
BGNE Old vs. Blueprint Medicines Corp
Performance |
| Timeline |
| BGNE Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Blueprint Medicines Corp |
BGNE Old and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BGNE Old and Blueprint Medicines
The main advantage of trading using opposite BGNE Old and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BGNE Old position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| BGNE Old vs. Ascendis Pharma AS | BGNE Old vs. Apellis Pharmaceuticals | BGNE Old vs. Akero Therapeutics | BGNE Old vs. Blueprint Medicines Corp |
| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |